Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug 17;18(8):e0290343.
doi: 10.1371/journal.pone.0290343. eCollection 2023.

The impact of COVID-19 on maternal death and fetal death, a cohort study in Brazil

Affiliations

The impact of COVID-19 on maternal death and fetal death, a cohort study in Brazil

Ana Paula Brioschi Dos Santos et al. PLoS One. .

Abstract

Objective: The study aimed to evaluate the risk of maternal death and fetal death among pregnant women infected with SARS-CoV-2.

Methods: This is a retrospective cohort study among pregnant women with secondary data from the National Live Births System (Sistema Nacional de Nascidos Vivos), National Mortality System (Sistema Nacional de Mortalidade), and e-SUS Health Surveillance System (Sistema e-SUS Vigilância em Saúde). Pregnant women confirmed for COVID-19 had positive RT-PCR between March 2020 and May 2021, pregnant women without COVID-19 were those without notification for disease. Maternal death, fetal death, and stillbirth were assessed as primary outcomes.

Results: We included 68,673 pregnant women not notified as suspected of COVID-19 and 1,386 with a confirmed diagnosis of COVID-19. Among pregnant women with COVID-19, 1013 (73.0%) were aged 20 to 34 years, 655 (47.2%) were brown, 907 (65.4%) had ≥ 8 years of education, in the third trimester of pregnancy (41.5%), undergoing cesarean section (64.5%). In adjusted analyses, COVID-19 in pregnancy had a higher risk of maternal death (relative risk [RR] 18.73-95% confidence interval [95%CI] 11.07-31.69), fetal death/stillbirth (RR 1.96-95%CI 1.18-3.25), preterm birth [RR 1.18-95%CI 1.01-1.39], cesarean delivery (RR 1.07-95%CI 1.02-1.11), and cesarean delivery occurring before the onset of labor (RR 1.33-95%CI 1.23-1.44).

Conclusion: COVID-19 may contribute to unfavorable pregnancy outcomes. Results showed that pregnant women infected with SARS-CoV-2 had a higher risk of maternal death, fetal death/stillbirth, preterm birth, cesarean delivery, and cesarean section occurring before the onset of labor.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Sample constitution.
SINASC—Live Births Information System (Sistema de Informação de Nascidos Vivos); e-SUS VS- e-SUS Health Surveillance System (e-SUS VS- Sistema e-SUS Vigilância em Saúde); SIM—Mortality Information System (Sistema de Informação de Mortalidade).

References

    1. JOHNS HOPKINS UNIVERSITY UNIVERSITY MEDICINE, J. H. U. COVID-19 Map—Johns Hopkins Coronavirus Resource Center. Available from: <https://coronavirus.jhu.edu/map.html> Accessed: February 4, 2023.
    1. Zambrano LD, Ellington S, Strid P, Galang R, Oduyebo T, Tong VT, et al.. Update: Characteristics of Symptomatic Women of Reproductive Age with Laboratory-Confirmed SARS-CoV-2 Infection by Pregnancy Status—United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020;69:1641–7. doi: 10.15585/mmwr.mm6944e3 - DOI - PMC - PubMed
    1. Vizheh M, Muhidin S, Aghajani F, et al.. Characteristics and outcomes of COVID-19 pneumonia in pregnancy compared with infected nonpregnant women. Int J Gynecol Obstet. 2021;153 (3):462–468. doi: 10.1002/ijgo.13697 - DOI - PMC - PubMed
    1. Huntley BJF, Huntley ES, Di Mascio D, Chen T, Berghella V, Chauhan SP. Rates of maternal and perinatal mortality and vertical transmission in pregnancies complicated by severe acute respiratory syndrome Coronavirus 2 (SARS-Co-V-2) infection: a systematic review. Obstet Gynecol. 2020;136:303–312. Lippincott Williams and Wilkins. doi: 10.1097/AOG.0000000000004010 - DOI - PubMed
    1. Wu C, Yang W, Wu X, et al.. Clinical Manifestation and Laboratory Characteristics of SARS-CoV-2 Infection in Pregnant Women. Virol Sin. 2020;35 (3):305–310. doi: 10.1007/s12250-020-00227-0 - DOI - PMC - PubMed